150 related articles for article (PubMed ID: 34204493)
1. Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010-2017.
Nowak MS; Romanowska-Dixon B; Grabska-Liberek I; Żurek M
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34204493
[No Abstract] [Full Text] [Related]
2. Incidence of retinoblastoma from 1958 to 1998 in Northern Europe: advantages of birth cohort analysis.
Seregard S; Lundell G; Svedberg H; Kivelä T
Ophthalmology; 2004 Jun; 111(6):1228-32. PubMed ID: 15177976
[TBL] [Abstract][Full Text] [Related]
3. Incidence and survival of retinoblastoma in Taiwan: a nationwide population-based study 1998-2011.
Li SY; Chen SC; Tsai CF; Sheu SM; Yeh JJ; Tsai CB
Br J Ophthalmol; 2016 Jun; 100(6):839-42. PubMed ID: 26370121
[TBL] [Abstract][Full Text] [Related]
4. Incidence of retinoblastoma and survival rate of retinoblastoma patients in Korea using the Korean National Cancer Registry database (1993-2010).
Park SJ; Woo SJ; Park KH
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2816-21. PubMed ID: 24692122
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project.
MacCarthy A; Draper GJ; Steliarova-Foucher E; Kingston JE
Eur J Cancer; 2006 Sep; 42(13):2092-102. PubMed ID: 16919773
[TBL] [Abstract][Full Text] [Related]
6. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
7. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
[TBL] [Abstract][Full Text] [Related]
10. Second primary tumors in retinoblastoma survivors: a study of 7 Asian Indian patients.
Kaliki S; Palkonda VAR
Int Ophthalmol; 2020 Dec; 40(12):3303-3308. PubMed ID: 32737729
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of retinoblastoma incidence and survival in Argentine children.
Moreno F; Sinaki B; Fandiño A; Dussel V; Orellana L; Chantada G
Pediatr Blood Cancer; 2014 Sep; 61(9):1610-5. PubMed ID: 24729462
[TBL] [Abstract][Full Text] [Related]
12. The Incidence of Retinoblastoma in South Africa: Findings from the South African National Cancer Registry (2004-2018).
Stuart KV; Shepherd DJ; Kruger M; Singh E
Ophthalmic Epidemiol; 2022 Dec; 29(6):681-687. PubMed ID: 34935580
[TBL] [Abstract][Full Text] [Related]
13. Incidence and geographic distribution of retinoblastoma in Ethiopia.
Sherief ST; Asfaw G; Abateneh A; Takewe S; Fufa D; Wondale T; Takele T; Dimaras H
BMC Ophthalmol; 2023 May; 23(1):231. PubMed ID: 37221479
[TBL] [Abstract][Full Text] [Related]
14. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma in Finland, 1964-2014: incidence and survival.
Nummi K; Kivelä TT
Br J Ophthalmol; 2021 Jan; 105(1):63-69. PubMed ID: 32217545
[TBL] [Abstract][Full Text] [Related]
16. The management of retinoblastoma.
Fabian ID; Onadim Z; Karaa E; Duncan C; Chowdhury T; Scheimberg I; Ohnuma SI; Reddy MA; Sagoo MS
Oncogene; 2018 Mar; 37(12):1551-1560. PubMed ID: 29321667
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma in Karachi, Pakistan.
Bhurgri Y; Muzaffar S; Ahmed R; Ahmed N; Bhurgri H; Usman A; Faridi N; Malik J; Kazi LA; Bashir I; Kayani N; Bhurgri A; Pervez S; Hasan SH; Soomro AH
Asian Pac J Cancer Prev; 2004; 5(2):159-63. PubMed ID: 15244518
[TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma in New South Wales 1975 to 2001.
Azar D; Donaldson C; Kalapesi F; Cumming R
J Pediatr Hematol Oncol; 2006 Oct; 28(10):642-6. PubMed ID: 17023823
[TBL] [Abstract][Full Text] [Related]
19. Incidence of retinoblastoma in the USA: 1975-2004.
Broaddus E; Topham A; Singh AD
Br J Ophthalmol; 2009 Jan; 93(1):21-3. PubMed ID: 18621794
[TBL] [Abstract][Full Text] [Related]
20. Incidence and survival of ocular melanoma in National Cancer Registry of Poland in 2010-2017.
Nowak MS; Romanowska-Dixon B; Grabska-Liberek I; Żurek M
Adv Clin Exp Med; 2022 Jun; 31(6):615-621. PubMed ID: 35349230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
